2012
DOI: 10.1136/thoraxjnl-2011-200730
|View full text |Cite
|
Sign up to set email alerts
|

Novel strategies in newborn screening for cystic fibrosis: a prospective controlled study

Abstract: Context Newborn screening for cystic fibrosis (CF) is included in many routine programmes but current strategies have considerable drawbacks, such as falsepositive tests, equivocal diagnosis and detection of carriers.Objective To assess the test performance of two newborn screening strategies for CF. Design, setting and participants In 2008 and 2009, CF screening was added to the routine screening programme as a prospective study in part of the Netherlands.Interventions Two strategies were performed in all new… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

5
54
0
5

Year Published

2014
2014
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 53 publications
(64 citation statements)
references
References 32 publications
5
54
0
5
Order By: Relevance
“…17 The attitude of the parents towards HLA-typing was evaluated by asking them about the reliability, possible regrets and whether they would consider HLA-typing in case they would have another child. Furthermore, parents rated the information they received on HLA-typing on a scale from 1 ('very bad') to 10 ('excellent').…”
Section: Questionnairesmentioning
confidence: 99%
“…17 The attitude of the parents towards HLA-typing was evaluated by asking them about the reliability, possible regrets and whether they would consider HLA-typing in case they would have another child. Furthermore, parents rated the information they received on HLA-typing on a scale from 1 ('very bad') to 10 ('excellent').…”
Section: Questionnairesmentioning
confidence: 99%
“…In Heidelberg wurde das Originalprotokoll zudem derart modifiziert, dass statt 2 IRT-abhän-giger PAP-Grenzwerte nur ein PAP-Grenzwert verwendet wurde [23]. Generelle Vorteile von IRT/PAP-gegenüber IRT/DNA-Protokollen sind die geringere Detektion von gesunden Heterozygoten und von Kindern mit unklarer CF-Diagnose (CFSPID), die nicht Ziel eines CF-NGS sind [9,12,21,22,26]. Nachteil rein biochemischer IRT/PAP-im Vergleich zu IRT/DNA-Protokollen ist jedoch ein schlechterer positiver Vorhersagewert (PPV) [9,12,21,22,26].…”
Section: Introductionunclassified
“…Generelle Vorteile von IRT/PAP-gegenüber IRT/DNA-Protokollen sind die geringere Detektion von gesunden Heterozygoten und von Kindern mit unklarer CF-Diagnose (CFSPID), die nicht Ziel eines CF-NGS sind [9,12,21,22,26]. Nachteil rein biochemischer IRT/PAP-im Vergleich zu IRT/DNA-Protokollen ist jedoch ein schlechterer positiver Vorhersagewert (PPV) [9,12,21,22,26]. 2012 schlug deshalb eine niederländische Arbeitsgruppe vor, das IRT/PAP-Protokoll mit der Suche nach populationsspezifischen CFTR-Mutationen als dritten Schritt zu kombinieren, wodurch der niedrige PPV angehoben werden kann [26].…”
Section: Introductionunclassified
See 2 more Smart Citations